v3.26.1
RISKS AND CONCENTRATIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 05, 2026
Jun. 25, 2026
Apr. 16, 2025
May 31, 2026
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
May 13, 2026
Concentration Risk [Line Items]                            
Deposit amount         $ 250,000           $ 250,000      
Cash balance         2,155,635           2,155,635   $ 4,258,605  
Remaining cash balance         254,446           254,446   159,564  
Accumulated deficit         8,867,148           8,867,148   $ 5,198,207  
Net loss         1,342,740 $ 1,028,964 $ 1,297,237 $ 1,005,824 $ 390,181 $ 322,199 3,668,941 $ 1,718,204    
Net cash in operating activities                     3,115,850 1,998,095    
Net proceeds from a secured promissory note       $ 2,765,930                    
Gross proceeds from common stock                     10,674 $ 7,725,350    
Principal amount         3,240,000           3,240,000      
Original issue discount         $ 439,571           $ 439,571      
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | No Customers [Member]                            
Concentration Risk [Line Items]                            
Concentration risk, percentage                     10.00%   10.00%  
At The Market Offering Agreement [Member]                            
Concentration Risk [Line Items]                            
Gross proceeds from common stock   $ 10,998,532                        
Note Purchase Agreement [Member]                            
Concentration Risk [Line Items]                            
Principal amount                           $ 3,240,000
Original issue discount                           $ 240,000
Note Purchase Agreement [Member] | Subsequent Event [Member]                            
Concentration Risk [Line Items]                            
Principal amount $ 1,620,000                          
Proceeds from purchase price 1,500,000                          
Original issue discount $ 120,000                          
IPO [Member]                            
Concentration Risk [Line Items]                            
Net cash in operating activities                     $ 3,115,850      
Over-Allotment Option [Member]                            
Concentration Risk [Line Items]                            
Sale of stock transactions     $ 8,901,000                      
Gross proceeds from common stock     $ 1,161,000